“Racial disparity” means that a condition may happen more often in a specific racial or ethnic group than in the general population. Previous studies have shown that racial disparities exist in pregnancy and postpartum outcomes, including hypertensive disorders of pregnancy. While systemic and structural racism have been studied and shown to contribute to the disparity in outcomes for Black women, genetic ancestral contributions can also be considered. In this study, researchers asked if a gene (called HMOX1, that encodes a protein called heme oxygenase-1, or “HO-1”) may vary in patients of different ancestries. Other research studies have shown that higher levels of HO-1 are linked with inflammation and poor functioning within the blood vessels of the placenta and other organs. Patients who have higher rates of this protein appear to be at higher risk of cardiovascular disease. Studying the relationship between the HMOX1 gene and HO-1 could provide key insights into why preeclampsia may occur more often in patients of specific ancestry.
Researchers studied DNA samples from over 1,200 individuals from 5 ancestral groups: Africa, the Americas, Europe, East Asia, and South Asia (including samples provided by the Preeclampsia Registry). Results showed that HMOX1 variants (meaning - a permanent change in the DNA sequence that makes up the gene) were more common in African women. This may help to explain one reason why preeclampsia may occur more often in women of African ancestry.
Take home message: In this study, HMOX1 gene variants were different depending on ancestry, and these genetic changes could be contributing to the racial disparity in hypertensive disorders of pregnancy. More work is needed to expand this study and to test if understanding genetic variants can improve the prediction of preeclampsia and/or help to customize health care for those at risk of hypertensive disorders of pregnancy.
Link: https://link.springer.com/article/10.1007/s43032-022-01001-1
Citation: Sun, T., Cruz, G.I., Mousavi, N. et al. HMOX1 Genetic Polymorphisms Display Ancestral Diversity and May Be Linked to Hypertensive Disorders in Pregnancy. Reprod. Sci. (2022). https://doi.org/10.1007/s43032-022-01001-1
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, and MD Jenny Sones, PhD, DVM.
Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Prompt and accurate diagnosis is necessary to prevent adverse outcomes. A study was completed to determine the accura...
Predicting preeclampsia has proven to be a challenge. Researchers have documented many differences in early pregnancy between those who eventually develop preeclampsia and those who do not. These incl...
The U.S. Preventive Services Task Force (USPSTF) and American College of Obstetricians and Gynecologists (ACOG) guidelines changed in 2021 to help prevent preeclampsia. Low-dose aspirin has been shown...
Hypertensive disorders of pregnancy (HDP), including preeclampsia, affect 1 in 6 pregnancies. HDP is a general term for a range of mild to severe outcomes. Until now there has not been a reliabl...
Although there is no definitive treatment for preeclampsia, early screening and detection can allow patients to ensure proper management throughout the remainder of the pregnancy. Currently, preeclam...